Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics awarded inducement equity grants to 41 new employees on September 1, 2026, under its 2024 Inducement Plan, as amended. The grants consist of time-based restricted stock units covering an aggregate 163,100 shares, with one-third vesting annually over three years, contingent on continued employment.
Key figures
- Grant date
- 2026-09-01
- Rsu shares
- 163100
- New hire count
- 41
- Vesting schedule
- one-third vesting annually over three years
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.